No Data
No Data
Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week With Event Participation and Investor/Partner Meetings
12 Health Care Stocks Moving In Friday's Pre-Market Session
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
Cadrenal Therapeutics Files to Sell 590K Shares of Common Stock for Holders
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co.
No Data